Cite
Monoclonal gammopathy of ocular significance (MGOS) – a short survey of corneal manifestations and treatment outcomes
MLA
Markus Munder, et al. “Monoclonal Gammopathy of Ocular Significance (MGOS) – a Short Survey of Corneal Manifestations and Treatment Outcomes.” Leukemia & Lymphoma, vol. 63, Nov. 2021, pp. 984–90. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....46e6bad44f0b4545d495a0ca43afe3c1&authtype=sso&custid=ns315887.
APA
Markus Munder, Walter Lisch, Alessandro Gozzetti, Camila Peña, Kitti Kormányos, Joanna Wasielica-Poslednik, Mohammad Al Hariri, Laura Rosiñol, Nóra Szentmáry, Mateusz Krzystanski, Xiang Zhou, Anna Waszczuk-Gajda, David H. Vesole, Gabor Mikala, Artur Jurczyszyn, & Laurent Garderet. (2021). Monoclonal gammopathy of ocular significance (MGOS) – a short survey of corneal manifestations and treatment outcomes. Leukemia & Lymphoma, 63, 984–990.
Chicago
Markus Munder, Walter Lisch, Alessandro Gozzetti, Camila Peña, Kitti Kormányos, Joanna Wasielica-Poslednik, Mohammad Al Hariri, et al. 2021. “Monoclonal Gammopathy of Ocular Significance (MGOS) – a Short Survey of Corneal Manifestations and Treatment Outcomes.” Leukemia & Lymphoma 63 (November): 984–90. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....46e6bad44f0b4545d495a0ca43afe3c1&authtype=sso&custid=ns315887.